Requesting conflicts of interest declarations from the European Medicines Agency: 3-year follow-up status
Abstract Aims We have previously described the European Medicines Agency’s (EMA) and the US Food and Drug Administration’s guidelines, each for a specific psychiatric indication, on how to design pivotal drug trials used in new drug applications. Here, we report on our efforts over 3 years to retrie...
| Huvudupphovsmän: | , , |
|---|---|
| Materialtyp: | Artikel |
| Språk: | English |
| Publicerad: |
Cambridge University Press
2024-01-01
|
| Serie: | Epidemiology and Psychiatric Sciences |
| Ämnen: | |
| Länkar: | https://www.cambridge.org/core/product/identifier/S2045796024000179/type/journal_article |